SCHEMBL809679

SCHEMBL809679

CC[C@](C)(C=O)[C@@H](O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.59
KDM4E B2RXH2 3/20 0.59
HPGD P15428 1/20 0.45
NPC1 O15118 2/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 6/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP3A4 P08684 2/20 0.39
CYP1A2 P05177 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
PHLPP2 Q6ZVD8 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 3/20 0.38
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
ADRB3 P13945 1/20 0.38
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL821788 1.00 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDNPC1POLB
SCHEMBL821786 1.00 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDNPC1POLB
SCHEMBL821787 1.00 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDNPC1POLB
SCHEMBL809480 0.81 ALDH1A1 (0.66) ALDH1A1KDM4EHPGDNPC1MAPT
SCHEMBL812445 0.81 ALDH1A1 (0.66) ALDH1A1KDM4EHPGDNPC1MAPT
SCHEMBL823034 0.79 ALDH1A1 (0.62) ALDH1A1KDM4EHPGDNPC1MAPT
SCHEMBL16651165 0.76 ALDH1A1 (0.72) ALDH1A1KDM4EHPGDNPC1MAPT
SCHEMBL14478233 0.74 ALDH1A1 (0.70) ALDH1A1KDM4EHPGDNPC1MAPT
SCHEMBL4175638 0.73 ALDH1A1 (0.68) ALDH1A1KDM4EHPGDNPC1MAPT
SCHEMBL14110844 0.73 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDNPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968734-B2 Organocatalysts and methods of use in chemical synthesis STC.UNM (US) 2011-06-28 US disclosed
US-20070244328-A1 Organocatalysts and Methods of Use in Chemical Synthesis STC.UNM (US) 2007-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244328-A1 Organocatalysts and Methods of Use in Chemical Synthesis SCO2, CBR1, CBR3 ALDH1A1 1287/4885KDM4E 3845/4885HPGD 868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.